Shadowbox Achieves SOC 2 Type II Compliance
19 Jul 2023
SAN DIEGO, July 19, 2023 /PRNewswire/ -- Shadowbox, a leading innovator in healthcare automation solutions, announced the successful completion of its System and Organization Control (SOC) 2 Type II audit. The audit, conducted by CPA firm Sensiba, LLP, affirms that Shadowbox meets the SOC 2 standards for security, availability, and confidentiality.
Continue Reading
Developed by the American Institute of Certified Public Accountants (AICPA), the SOC 2 information security standard is an audit report that validates controls relevant to security, availability, processing integrity, confidentiality, and privacy. With no noted exceptions, Sensiba issued a "clean" audit opinion.
"Obtaining our SOC 2 Type II underscores our commitment to the highest level of security," said Gregory A. Stein, CEO
Tweet this
"Obtaining our SOC 2 Type II attestation underscores our ongoing commitment to the highest level of security, compliance and data integrity," said Gregory A. Stein, Shadowbox Founder and CEO. "Our customers and partners can use Shadowbox with the highest confidence that our platform is tightly monitored and managed."
Shadowbox redefines workflow automation between healthcare providers and their customers, instantly connecting their systems to a library of electronic health records (EHRs). Shadowbox's patented technology enables complete, accurate, and cost-effective transfer of patient data, freeing providers from costly and time-consuming traditional integration projects. This independent validation of security controls is crucial for customers in highly regulated industries such as healthcare.
About Shadowbox
Shadowbox is a ground-breaking, patented automation platform built for healthcare. By powering a browser with security, AI, and user-driven cross-application connections, Shadowbox offers instant integration and automation across the healthcare ecosystem.
SOURCE Shadowbox, Inc.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.